Cardiology Flashcards
Highest valve risk of clotting
Mitral > aortic
AC after Bioprosthetic Valves:
- Aortic
- TAVR
- Mitral
Aortic: ASA 81 mg x 3 mons
TAVR: ASA 81 mg + clopidogrel 75 mg x 6 mons, then ASA indefinetly
Mitral: Warfarin 2-3 INR x 3 months, then ASA 81 mg indefinetly
AC after Mechanical Valves:
Mitral
Aortic
Mitral: 2.5-3.5 INR with warfarin
Aortic: 2-3 INR with warfarin
+ ASA 81mg indefinetly
VTE treatment with edoxaban and dabigatran
Requires 5 days of parental AC then initiate
Cancer-related VTE treatment options
LMWH
Xarelto
Edoxaban
Fondaparinux VTE treatment doses
< 50kg: 5 mg
50 - 100 kg: 7.5 mg
> 100 kg: 10 mg
AC if on strong CYP3A4 Inhibitors (PI’s, ketoconazole)
Avoid Xarelto
50% dose reduction with Eliquis
Calculate protamine dose to reverse UFH
1 mg protamine - 100 units of UFH
Calculate UFH in past 3 hrs: 100% UFH in past hour 50% UFH in previous hour 25% UFH in previous hour Convert to mg protamine
Calculate protamine dose to reverse enoxaparin
If Lovenox given in past 8 hours:
1mg protamine = 1 mg enoxaparin
If Lovenox given > 8 hours, give 0.5 mg protamine = 1 mg enoxaparin
AC reversal agents
Protamine = UFH, enoxaparin
Pradaxa = Idarucizumab
Xa inhibitors = PCC, andexanet alfa
Warfarin = rapid use 4PCC, or PO vitamin K 5 mg if INR > 10 OR INR 4.5-10 if risk factors. Otherwise omit.
Bariatric surgery AC of choice
enoxaparin 40 mg BID
AC of choice in CABG
LMWH > Heparin due to risk of HIT
AC of choice in Knee/hip replacement
Both:
- Apixaban 2.5 mg BID 12-24hr post-op
- Xarelto 10 mg daily 6-10 hours post-op
- Lovenox 30 mg BID (can use 40 mg daily in HIP ONLY)
- Fondaparinux 2.5 mg SC qd
- Dabigatran approved for hip only
Knee - about 10 days
Hip - about 4-6 weeks
AC of choice in medically ill / critical ill
Medical: UFH SC q8H > q12h, Xarelto 10 mg qd, enoxaparin 40 mg daily, fondaparinux 2.5 mg daily
Critical: LMWH or UFH
Surgery hold times for DOACS and warfarin
Low risk: 1 day before, restart 1 day after
Mod-high risk: 2 days before, restart 3 days after
Warfarin: hold 5 days before, may bridge with enoxaparin